348 related articles for article (PubMed ID: 12701679)
1. Molecular pathogenesis of precursor lesions of pancreatic ductal adenocarcinoma.
Biankin AV; Kench JG; Dijkman FP; Biankin SA; Henshall SM
Pathology; 2003 Feb; 35(1):14-24. PubMed ID: 12701679
[TBL] [Abstract][Full Text] [Related]
2. Precursor lesions in pancreatic cancer: morphological and molecular pathology.
Scarlett CJ; Salisbury EL; Biankin AV; Kench J
Pathology; 2011 Apr; 43(3):183-200. PubMed ID: 21436628
[TBL] [Abstract][Full Text] [Related]
3. Progressive genomic alterations in intraductal papillary mucinous tumours of the pancreas and morphologically similar lesions of the pancreatic ducts.
Soldini D; Gugger M; Burckhardt E; Kappeler A; Laissue JA; Mazzucchelli L
J Pathol; 2003 Apr; 199(4):453-61. PubMed ID: 12635136
[TBL] [Abstract][Full Text] [Related]
4. [Precursors to pancreatic cancer].
Søreide K; Immervoll H; Molven A
Tidsskr Nor Laegeforen; 2006 Mar; 126(7):905-8. PubMed ID: 16554881
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic intraepithelial neoplasia in heterotopic pancreas: evidence for the progression model of pancreatic ductal adenocarcinoma.
Zhang L; Sanderson SO; Lloyd RV; Smyrk TC
Am J Surg Pathol; 2007 Aug; 31(8):1191-5. PubMed ID: 17667542
[TBL] [Abstract][Full Text] [Related]
6. Mucin gene expression in intraductal papillary-mucinous pancreatic tumours and related lesions.
Terris B; Dubois S; Buisine MP; Sauvanet A; Ruszniewski P; Aubert JP; Porchet N; Couvelard A; Degott C; Fléjou JF
J Pathol; 2002 Aug; 197(5):632-7. PubMed ID: 12210083
[TBL] [Abstract][Full Text] [Related]
7. Precursor lesions of pancreatic cancer: molecular pathology and clinical implications.
Singh M; Maitra A
Pancreatology; 2007; 7(1):9-19. PubMed ID: 17449961
[TBL] [Abstract][Full Text] [Related]
8. Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia.
Ozaki N; Ohmuraya M; Ida S; Hashimoto D; Ikuta Y; Chikamoto A; Hirota M; Baba H
J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):620-7. PubMed ID: 23475261
[TBL] [Abstract][Full Text] [Related]
9. Genetic alterations in precancerous pancreatic lesions and their clinical implications.
Turrini O; Cano C; Legoffic A; Delpero JR; Dagorn JC; Iovanna J
Gastroenterol Clin Biol; 2009; 33(10-11):1028-35, e1-9. PubMed ID: 19766418
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic intraepithelial neoplasia-can we detect early pancreatic cancer?
Haugk B
Histopathology; 2010 Oct; 57(4):503-14. PubMed ID: 20875068
[TBL] [Abstract][Full Text] [Related]
11. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects.
Adsay NV; Basturk O; Cheng JD; Andea AA
Semin Radiat Oncol; 2005 Oct; 15(4):254-64. PubMed ID: 16183479
[TBL] [Abstract][Full Text] [Related]
12. [Pathology of intraductal papillary-mucinous tumor of the pancreas].
Nobukawa B; Suda K; Yamasaki S; Takase M; Fukumura Y; Shiono S
Nihon Geka Gakkai Zasshi; 2003 Jun; 104(6):439-42. PubMed ID: 12854489
[TBL] [Abstract][Full Text] [Related]
13. Where and when does pancreatic carcinoma start?
Lüttges J; Hahn S; Klöppel G
Med Klin (Munich); 2004 Apr; 99(4):191-5. PubMed ID: 15085289
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological correlates of pancreatic intraepithelial neoplasia: a comparative analysis of 82 cases with and 152 cases without pancreatic ductal adenocarcinoma.
Andea A; Sarkar F; Adsay VN
Mod Pathol; 2003 Oct; 16(10):996-1006. PubMed ID: 14559982
[TBL] [Abstract][Full Text] [Related]
15. [Intraepithelial neoplasms (PanIN) and intraductal papillary-mucinous neoplasms (IPMN) of the pancreas as precursor lesions of pancreatic carcinoma].
Ott C; Heinmöller E; Gaumann A; Schölmerich J; Klebl F
Med Klin (Munich); 2007 Feb; 102(2):127-35. PubMed ID: 17323019
[TBL] [Abstract][Full Text] [Related]
16. Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray.
Maitra A; Adsay NV; Argani P; Iacobuzio-Donahue C; De Marzo A; Cameron JL; Yeo CJ; Hruban RH
Mod Pathol; 2003 Sep; 16(9):902-12. PubMed ID: 13679454
[TBL] [Abstract][Full Text] [Related]
17. Clinical importance of precursor lesions in the pancreas.
Hruban RH; Takaori K; Canto M; Fishman EK; Campbell K; Brune K; Kern SE; Goggins M
J Hepatobiliary Pancreat Surg; 2007; 14(3):255-63. PubMed ID: 17520200
[TBL] [Abstract][Full Text] [Related]
18. Current understanding of precursors to pancreatic cancer.
Takaori K
J Hepatobiliary Pancreat Surg; 2007; 14(3):217-23. PubMed ID: 17520195
[TBL] [Abstract][Full Text] [Related]
19. The molecular genetics of pancreatic ductal carcinoma.
Sohn TA
Minerva Chir; 2002 Oct; 57(5):561-74. PubMed ID: 12370658
[TBL] [Abstract][Full Text] [Related]
20. Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues.
Aichler M; Seiler C; Tost M; Siveke J; Mazur PK; Da Silva-Buttkus P; Bartsch DK; Langer P; Chiblak S; Dürr A; Höfler H; Klöppel G; Müller-Decker K; Brielmeier M; Esposito I
J Pathol; 2012 Apr; 226(5):723-34. PubMed ID: 21984419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]